1. P784: A PHASE I/II STUDY OF VENETOCLAX IN COMBINATION WITH ASTX727 (DECITABINE/CEDAZURIDINE) IN TREATMENT‐NAÏVE HIGH‐RISK MYELODYSPLASTIC SYNDROME (MDS) OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML). (23rd June 2022) Authors: Venugopal, S.; kantarjian, H.; Maiti, A.; Short, N.; Montalban-Bravo, G.; Alvarado, Y.; Chien, K. S.; Kanagal-Shamanna, R.; Pemmaraju, N.; Daver, N.; Kadia, T.; Borthakur, G.; Jabbour, E.; Garcia-Manero, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗